Article R1211-5
The health establishment carrying out the removal shall, where applicable, pay compensation for any loss of earnings suffered by the donor.Compensation for loss of earnings is paid on presentation of…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 3841–3850 of 18228 articles for “Art. 5° ter”
The health establishment carrying out the removal shall, where applicable, pay compensation for any loss of earnings suffered by the donor.Compensation for loss of earnings is paid on presentation of…
…du médicament et des produits de santé. Except in urgent cases, these decisions may only be taken after the authorisation holder has been given the opportunity to present its observations.
The Board of Directors may only validly deliberate if at least half of its members with voting rights are present. If the quorum is not reached, the Board is reconvened with the same agenda within fif…
The Agence nationale de sécurité du médicament et des produits de santé and the regional haemovigilance and transfusion safety coordinator simultaneously receive serious incident report forms, adverse…
…ble for supervising a blood depot mentioned in article R. 1221-20, must, for this activity, be registered in sections G or H of the national order of pharmacists, or in section E if they practise in a…
…responsible for the import and, where applicable, the recipient establishment if it is not the importer, the nature and quantity of the imported product and the intended use. It specifies its period o…
Decisions by the Director General of the Agence nationale de sécurité des médicaments et des produits de santé, following consultation with the Etablissement français du sang and the Armed Forces Bloo…
The provisions of this section shall apply to biomedical research on labile blood products, without prejudice to the provisions of Title II of Book I of Part One of this Code.
A plasma paste is any intermediate product resulting from the fractionation of plasma, whatever its level of processing, which cannot be used as it is for administration to humans, and which is intend…
…ring labile blood products intended for direct therapeutic use in blood establishments must be registered in sections G or H of the national order of pharmacists or in section E if they practise in an…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More